ESG

Keyfactor's new server on AWS aims to give each AI agent a unique digital identity, pioneering a new era of security for autonomous systems.

A Texas optometrist launches a new supplement aiming to fight dry eye and glare from the inside out. Can this clean-label formula change eye care?

As brands like She Said Yes champion lab-grown gems, consumers are embracing a new era of ethical, affordable luxury. What does this mean for tradition?

A new partnership in Northeast Ohio allows health plan members to buy nutritious groceries with a simple card swipe, turning local stores into health hubs.

Pfizer projects lower 2026 earnings as COVID sales wane and patents expire, shifting focus to a multi-billion dollar R&D push for future growth.

The world's largest bamboo resort opens in a Vietnamese heritage site, blending Hmong culture with advanced wellness for a new kind of regenerative travel.

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

Subsea 7 has landed a contract worth up to $300M for Chevron's Gorgon Stage 3 project, reinforcing its key role in Australia's deepwater energy sector.

Beyond Nordic hype, Helsinki's compact size and collaborative spirit are fostering a unique, accessible, and innovative culinary scene on its own terms.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

A new Google-TotalEnergies deal in Malaysia reveals the collision of a data boom and green energy goals, a key test for the region's strategic future.

A new partnership between EcoFlow and Octopus Energy turns homes into automated power stations, slashing bills and reshaping the UK's energy grid.

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

New rankings name Germany's top cancer hospitals, but the real story is the rise of platforms shaping a multi-billion dollar global health market.

CMS's new ACCESS model spotlights virtual care, positioning firms like FlyteHealth to lead a tech-driven transformation in managing chronic illness.

How a Defense Logistics Agency grant to 6K Energy for advanced cathode tech aims to sever risky foreign supply chains and secure America's defense.

A new partnership claims to power an AI with meditated 'love' from at-risk communities. Is this a bold new paradigm or a controversial social experiment?